Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From co-Administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2012
At a glance
- Drugs Rosuvastatin/choline fenofibrate (Primary) ; Choline fenofibrate; Rosuvastatin
- Indications Acute coronary syndromes; Atherosclerosis; Hyperlipidaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AstraZeneca
- 10 Sep 2012 Company (Astrazeneca) added as reported by ClinicalTrials.gov record.
- 14 Nov 2008 Status changed from not yet recruiting to completed as reported by ClincalTrials.gov.
- 22 Aug 2008 New trial record.